Heart failurecardiomyopathyimplantable cardioverter-defibrillatorGiven recent advances in both pharmacologic and non-pharmacologic strategies for improving outcomes related to chronic systolic heart failure, heart failure with recovered ejection fraction (HFrecEF) is now recognized as a distinct clinical entity ...
3. Bardy GH,et al. SCD-HeFT. NEJM 2005; 352;3:225-237 4. Saxon, Leslie et al. Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circ 2006; ...
EveryN,etal.RiskofSuddenversusNonSuddenCardiacDeathinPatientwithCoronaryArteryDisease.AmHeartJ2002;144:390-6.美国SCA的发病情况在美国,所有心脏原因引起的死亡中,SCA大约占63%1在发达国家中,SCA是最常见的死亡原因之一1 MMWR.Vol51(6)Feb.15,2002.2MyerbergRJ,CatellanosA.CardiacArrestandSuddenCardiacDeath.In:Bra...
参考文献: 1. Yafasova A, Butt JH, Elming MB, et al. Long-term Follow-up of the The Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH). Circulation. 2022; 145: 427–436. doi:10.1161/CIRCULATIONAHA.121.056072. Epub ahea...
9.Blatt JA, Poole JE, Johnson GW, et al. SCD-HeFT Investigators.No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol, 2008, 52(7): 551-556. 10.Michowitz Y, Lellouche N, Contractor T,et al. Defibrillation th...
来源:Prevention of sudden death in heart failure with reduced ejection fraction: Do we still need ICD for primary prevention?. Eur J Heart Fail, 26 June 2022 转载:请标明“中国循环杂志” 很多疑难复杂病例,一个医生一生也只能见到一次 长...
来源:Prevention of sudden death in heart failure with reduced ejection fraction: Do we still need ICD for primary prevention?. Eur J Heart Fail, 26 June 2022 转载:请标明“中国循环杂志” 很多疑难复杂病例,一个医生 一生 也只能见到 一次
来源:Huang D, et al. Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China. ESC Heart Fail. 2020 Nov 9. Epub ahead of print. 转载:请标明“中国循环杂志” 很多疑难复杂病例,一个医生 一生 也只能见到 一次 ...
[4]Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL et al: Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circ...
SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)入选2521例中度心衰(HF)患者,随机分入胺碘酮、安慰剂或ICD组。初始研究随访结束于2003年10月31日。经过中位数45.5个月随访,与安慰剂比较,胺碘酮不能降低死亡率,而ICD明显降低全因死亡率23%。